Insight into global burden of gastroesophageal reflux disease: Understanding its reach and impact

doi:10.4292/wjgpt.v16.i1.97918

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (24)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-6)

Sum=19

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=1

Publishing Process of This Article

Item

Count

Browse

Download

Sum=0

Mar 5, 2025 (publication date) through Mar 3, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Pharmacol Ther. Mar 5, 2025; 16(1): 97918
Published online Mar 5, 2025. doi: 10.4292/wjgpt.v16.i1.97918

Table 3 Diseases with symptoms overlapping with gastroesophageal reflux disease

Ref.	Diseases with overlapping symptoms
[115]	Eosinophilic esophagitis
[116]	Infectious esophagitis
	Esophageal candidiasis
	Herpes and cytomegalovirus esophagitis
[117]	Drug-induced esophagitis
[118]	Achalasia and esophageal motility disorders
[119]	Pharyngeal and esophageal diverticula, rings, and webs
[120]	Disorders of gastric motility/ gastroparesis
[121]	Gastritis & peptic ulcer disease
[122]	Gluten-related disorders
[123]	Functional gastrointestinal disorders: Functional chest pain, functional heartburn, reflux hypersensitivity, globus sensation, functional dysphagia, functional dyspepsia, postprandial distress syndrome, epigastric pain syndrome, belching disorders, and rumination syndrome
[124]	Functional abdominal bloating/distension and esophageal and gastric carcinoma
[125]	Cardiac disease
[126]	Gall bladder and pancreatic diseases

Citation: Wickramasinghe N, Devanarayana NM. Insight into global burden of gastroesophageal reflux disease: Understanding its reach and impact. World J Gastrointest Pharmacol Ther 2025; 16(1): 97918
URL: https://www.wjgnet.com/2150-5349/full/v16/i1/97918.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v16.i1.97918